Assoc Dir/Director, Regional Marketing & Customer Engagement East Coast and West Coast Regions - Kura Oncology
San Diego, CA
About the Job
Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.
At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.
As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.
To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.
We are seeking an Associate Director/Director of Regional Marketing & Customer Engagement who will drive strategy, planning, and execution in the East and West regions.
The Associate Director/ Director of Regional Marketing Customer Engagement will engage with National and Regional Hematology and Oncology Thought Leaders. In this role you will coordinate and execute the Thought Leader engagement strategy, ensuring alignment with the organization's corporate strategy, brand positioning, brand strategy and lifecycle management plans to ensure brand success and ongoing optimization.
Essential Job Functions
- Regional Marketing Lead, driving regional marketing and engagement strategies and initiatives to support delivery and optimization of brand positioning, brand strategy and life-cycle planning.
- Collaborate closely with internal stakeholders across commercial functions, including field medical leadership, to identify areas for shared Thought Leader insights, and to align strategies and execute tactics effectively.
- Partner with Medical Affairs leadership and field Medical Scientific Liaisons (MSLs) to ensure a coordinated, compliant approach in the external engagement with National and Regional Thought Leaders
- Partner with sales leadership and field sales representatives to ensure a coordinated, compliant approach in the external engagement with National and Regional Thought Leaders
- Inform and execute on the National and Regional Thought Leader strategy, translating it into commercial insights, messaging and contributing to broader communication strategies and plans.
- Foster advocacy with Hematology-Oncology Thought Leaders to ensure effective collaboration and support for investigational therapies and future anticipated FDA-approved treatments.
- Plan and oversee marketing-led, cross-functionally coordinated Thought Leader engagements at various conferences, events, and meetings, ensuring compliance with regulatory and legal standards.
- Collaborate regularly with the brand team to provide strategic input from customer insights to inform strategy, planning, messaging, tactics, and program development.
- Identify and successfully execute opportunities for strategic programs that support business goals.
- Foster an environment that prioritizes positive patient, caregiver, and healthcare provider experiences.
- Adapt strategies as needed to support pre-launch preparations and post-launch pull-through, navigating a dynamic market.
- Collaborate cross-functionally to execute business plans and contribute to the Customer Engagement team's objectives.
- Manage CRM to maintain accurate account and contact details.
- Collaborate with the Regional Marketing Team to build a speaker bureau, train speakers and support speaker program management and monitoring.
- Responsible for collaborating with annual planning and management oversite of the functional budgets and return on investments.
- Partner with Analytics and Insights to better understand regional treatment pattern variations to inform peer to peer program placement
- Ensure all activities and practices adhere to regulatory and legal compliance standards.
Job Requirements
- BA/BS or healthcare equivalent degree required, and advanced degree (ex. MBA, PhD) preferred.
- Minimum 8+ years of previous pharmaceutical, biotech, and/or medical experience in Hematology/Oncology with a strong knowledge of the pharmaceutical marketplace and deep understanding of industry and broader trends within the healthcare landscape.
- Minimum of 3+ years combined experience in Key Customer Engagement and/or Regional Marketing in Hematology/Oncology required.
- Proven ability to access and influence C/D-Suite level stakeholders.
- Demonstrated strong strategic vision, leadership, and project management skills.
- Strong interpersonal, verbal and written communication skills.
- Ability to form strong, constructive internal and external professional relationships.
- Successful new product and indication expansion launches in Hematology, Oncology and other rare diseases required.
- Prior pharma/biotech start-up experience preferred.
- Technologically savvy and committed to leveraging data and advanced analytics daily to drive business results.
- Ability to travel on a frequent overnight basis, with occasional weekend travel to medical congresses, depending on business needs.
The base range for an Associate Director is $195,000 - $220,000 and a Director is $210,000 - $252,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.
Kura's Values that are used for candidate selection and performance assessments:
- We work as one for patients
- We are goal-focused and deliver with excellence
- We are science-driven courageous innovators
- We strive to bring out the best in each other and ourselves
The Kura Package
- Career advancement/ development opportunities
- Competitive comp package
- Bonus
- 401K + Employer contributions
- Generous stock options
- ESPP Plan
- 20 days of PTO to start
- 18 Holidays (Including Summer & Winter Break)
- Generous Benefits Package with a variety of plans available with a substantial employer match
- Paid Paternity/Maternity Leave
- In-Office Catered lunches
- Home Office Setup
- Lifestyle Spending Stipend
- Commuter Stipend (Boston Office)
- Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!
Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of blood cancers and solid tumors. The company's diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology's approach to drug development is focused on rapidly translating novel science into life-saving medicines. Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts.
Kura's pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib, a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction, has received Breakthrough Therapy Designation for the treatment of R/R NPM1-mutant acute myeloid leukemia (AML). Kura has completed enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML (KOMET-001). The Company is also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective farnesyl transferase inhibitor (FTI), is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma (KURRENT-HN). Kura is also evaluating KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies (FIT-001). For additional information, please visit Kura's website at www.kuraoncology.com and follow us on X and LinkedIn.
Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.
